FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Potassium Chloride Concentrate Injection
Status: Currently in Shortage
»Date first posted: 11/02/2021
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

B. Braun Medical Inc. (Revised 05/09/2022)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
(2 mEq K /mL) 250mL bulk package Catalog# S9402-11(NDC 0264-1940-20) Product on allocation to contracted customers. Discontinuation of manufacturing
Concentrated Potassium Chloride Injection USP 250 mL Plastic Bag P9402 (NDC 0264-1944-20) Product on allocation for contracted customers Increased demand

Baxter Healthcare (Revised 07/01/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0826 (NDC 0338-0709-48) Available on allocation Demand increase for the drug
10 mEq/50 mL in VIAFLEX Plastic Container; Product Code 2B0821 (NDC 0338-0705-41) Available on allocation Demand increase for the drug
20 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0827 (NDC 0338-0705-48) Limited Supply on Allocation; Recovery late June 2022 Demand increase for the drug
20 mEq/50 mL in VIAFLEX Plastic Container; Product Code 2B0822 (NDC 0338-0703-41) Limited Supply on Allocation; Recovery mid-July 2022 Demand increase for the drug
40 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0824 (NDC 0338-0703-48) Available on allocation

Fresenius Kabi USA, LLC (Revised 07/01/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
60 mEq per 30 mL (2 mEq per mL), Multi dose, plastic vial, (NDC 63323-967-30) Backordered. Next release July 2022. Manufacturing delays
10 mEq per 5 mL(2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-05) Available Manufacturing delays
20 mEq per 10 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-10) Available Manufacturing delays
40 mEq per 20 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-20) Backordered. Next release July 2022. Manufacturing delays

Hospira, Inc. (Revised 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mEq/5 mL (2 mEq/mL) Single Dose Glass Fliptop Vial (NDC 0409-6635-01) Next Delivery: July 2022; Estimated Recovery: August 2022 Demand increase for the drug
20 mEq/10 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 0409-6651-06) Next Delivery: July 2022; Estimated Recovery: November 2022 Demand Increase for the drug
40 mEq/20 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 00409-6653-05) Next Delivery: June 2022; Estimated Recovery: September 2022 Demand increase for the drug

ICU Medical, Inc. (Reverified 07/15/2022)

Company Contact Information:
877-976-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Potassium Chloride Injection, 20 mEq/50 mL (Legacy Hospira NDC 0409-7077-14) (ICU Medical NDC 0990-7077-14) Allocation Demand Increase for the Drug
Potassium Chloride Injection, 10 mEq/100 mL (Legacy Hospira NDC 0409-7074-26) (ICU Medical NDC 0990-7074-26) Allocation Demand Increase for the Drug
Potassium Chloride Injection, 10 mEq/50 mL (Legacy Hospira NDC 0409-7075-14) (ICU Medical NDC 0990-7075-14) Allocation Demand Increase for the Drug
Potassium Chloride Injection, 20 mEq/100 mL (Legacy Hospira NDC 0409-7075-26) (ICU Medical NDC 0990-7075-26) Allocation Demand Increase for the Drug
Potassium Chloride Injection, 40 mEq/100 mL (Legacy Hospira NDC 0409-7077-26) (ICU Medical NDC 0990-7077-26) Available Demand Increase for the Drug

Nexus Pharmaceuticals, Inc. (New 02/02/2022)

Company Contact Information:
888-806-4606

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
29.8 g/L (20 mEq) 50 mL (NDC 14789-107-08) Backordered. Available early March 2022.
29.8 g/L (40 mEq) 100 mL (NDC 14789-107-16) Backordered. Available early March 2022.
14.9 g/L (20 mEq) 100 mL (NDC 14789-108-16) Backordered. Available early March 2022.
14.9 g/L (10 mEq) 50 mL (NDC 14789-108-08) Backordered. Available early March 2022.
7.45 g/L ( 10 mEq) 100 mL (NDC 14789-109-16) Backordered. Available early March 2022.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English